HLA-DRA Mouse Monoclonal Antibody [Clone ID: LN3]
Other products for "HLA-DRA"
Specifications
| Product Data | |
| Clone Name | LN3 |
| Applications | FC |
| Recommended Dilution | Flow, IHC |
| Reactivities | Human |
| Host | Mouse |
| Clonality | Monoclonal |
| Formulation | Aqueous buffer, 0.09% sodium azide, may contain carrier protein/stabilizer |
| Concentration | lot specific |
| Purification | Affinity purified |
| Conjugation | Unconjugated |
| Storage | Store at -20°C as received. |
| Stability | Stable for 12 months from date of receipt. |
| Gene Name | major histocompatibility complex, class II, DR alpha |
| Database Link | |
| Background | The LN3 mAb reacts with the human major histocompatibility complex (MHC) class II, HLA-DR. HLA-DR is expressed on the surface of human antigen presenting cells (APC) including B cells, monocytes, macrophages, DCs, and activated T cells. HLA-DR is a heterodimeric transmembrane protein composed of α and β subunits and plays an important role in the presentation of peptides to CD4+ T lymphocytes. |
| Synonyms | HLA-DRA1; MLRW |
| Reference Data | |
| Protein Families | Transmembrane |
| Protein Pathways | Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Hematopoietic cell lineage, Systemic lupus erythematosus, Type I diabetes mellitus, Viral myocarditis |
Documents
| Product Manuals |
| FAQs |
{0} Product Review(s)
0 Product Review(s)
Submit review
Be the first one to submit a review
Product Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.
Germany
Japan
United Kingdom
China